WATSON 460 (Glipizide 5 mg)
Pill with imprint WATSON 460 is White, Round and has been identified as Glipizide 5 mg. It is supplied by Watson Laboratories, Inc..
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 460
Glipizide
- Imprint
- WATSON 460
- Strength
- 5 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Sulfonylureas
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
lactose anhydrous,
microcrystalline cellulose,
corn starch,
stearic acid
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-0460 | Watson Pharmaceuticals, Inc. |
| 54569-3841 | A-S Medication Solutions, LLC (repackager) |
| 63874-0316 | Altura Pharmaceuticals Inc. (repackager) |
| 55289-0806 | PDRX Pharmaceuticals Inc. (repackager) |
| 53002-0446 | Pharmedix (repackager) |
More about glipizide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 61 Reviews
- Drug class: sulfonylureas
Consumer resources
- Patient Information
- Glipizide (Advanced Reading)
- Glipizide Extended-Release Tablets
- Glipizide Tablets
- Other brands
- Glucotrol, Glucotrol XL
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.